Pierre Verrelle
Overview
Explore the profile of Pierre Verrelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1098
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
El Ouadih Y, Pereira B, Biau J, Claise B, Chaix R, Verrelle P, et al.
Curr Oncol
. 2022 Apr;
29(4):2823-2834.
PMID: 35448204
(1) Background: Glioblastoma multiforme (GBM) shows complex mechanisms of spreading of the tumor cells, up to remote areas, and little is still known of these mechanisms, thus we focused on...
12.
Beddok A, Calugaru V, De Marzi L, Graff P, Dumas J, Goudjil F, et al.
Crit Rev Oncol Hematol
. 2022 Apr;
174:103655.
PMID: 35398521
Since the development of new radiotherapy techniques that have improved healthy tissue sparing, reirradiation (reRT) has become possible. The selection of patients eligible for reRT is complex given that it...
13.
Pinson M, Court F, Masson A, Renaud Y, Fantini A, Bacoeur-Ouzillou O, et al.
Hum Mol Genet
. 2022 Mar;
31(15):2606-2622.
PMID: 35298627
Besides the consequences of retrotransposition, long interspersed element 1 (L1) retrotransposons can affect the host genome through their antisense promoter. In addition to the sense promoter, the evolutionarily recent L1...
14.
Verrelle P, Meseure D, Berger F, Forest A, Leclere R, Nicolas A, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439087
Effective biomarkers predictive of the response to treatments are key for precision medicine. This study identifies the staining pattern of the centromeric histone 3 variant, CENP-A, as a predictive biomarker...
15.
Ginzac A, Dupic G, Brun L, Molnar I, Casile M, Durando X, et al.
BMC Cancer
. 2021 Jul;
21(1):864.
PMID: 34320940
Background: Surgery is an important therapeutic option for brain metastases. Currently, postoperative stereotactic radiosurgery (SRT) leads to 6-month and 1-year local control estimated at 70 and 62% respectively. However, there...
16.
Boiteux E, Court F, Guichet P, Vaurs-Barriere C, Vaillant I, Chautard E, et al.
Mol Oncol
. 2021 Mar;
15(8):1995-2010.
PMID: 33720519
In human, the 39 coding HOX genes and 18 referenced noncoding antisense transcripts are arranged in four genomic clusters named HOXA, B, C, and D. This highly conserved family belongs...
17.
Silina L, Maksut F, Bernard-Pierrot I, Radvanyi F, Crehange G, Megnin-Chanet F, et al.
Cancers (Basel)
. 2021 Jan;
13(1).
PMID: 33396795
Bladder cancer is among the top ten most common cancer types in the world. Around 25% of all cases are muscle-invasive bladder cancer, for which the gold standard treatment in...
18.
Dupic G, Brun L, Molnar I, Leyrat B, Chassin V, Moreau J, et al.
Radiother Oncol
. 2020 Nov;
154:260-268.
PMID: 33245944
Background: Stereotactic radiotherapy (SRT) should be applied with a biologically effective dose with an α/β of 12 (BED) ≥ 40 Gy to reach a 1-year local control (LC) ≥ 70%....
19.
Dupic G, Urcissin M, Mom T, Verrelle P, Dedieu V, Molnar I, et al.
Front Oncol
. 2020 Nov;
10:598841.
PMID: 33194765
Background: Stereotactic radiosurgery (SRS) is a common treatment option for vestibular schwannomas. Historically, a dose de-escalation of the marginal prescribed dose from 16 Gy to 12-13 Gy has been done...
20.
El Ouadih Y, Lemaire J, Vigier B, Gabrillargues J, Mulliez A, Dedieu V, et al.
World Neurosurg
. 2019 Dec;
136:e141-e148.
PMID: 31874295
Background: Numerous studies have assessed the predictive factors for the arteriovenous malformation (AVM) response to stereotactic radiosurgery (SRS). However, only a few have discussed the causes of failure. The aim...